GALMED PHARMACEUTICALS LTD. Marketable Securities (Current)
GALMED PHARMACEUTICALS LTD. (GLMD) had Marketable Securities (Current) of $5.88 million as of 2026-06-30, per its 6-K filed 2026-09-02.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2026-09-02
- 2026-06-30: Marketable Securities, Current $5.88M.
- 2025-12-31: Marketable Securities, Current $7.03M.
- 2025-09-30: Marketable Securities, Current $8.18M.
- 2025-06-30: Marketable Securities, Current $8.10M.
| Period end | Marketable Securities, Current | Marketable Securities, Current as first filed |
|---|---|---|
| 2026-06-30 | $5.88M 6-K · filed 2026-09-02 | |
| 2025-12-31 | $7.03M 6-K · filed 2026-09-02 | |
| 2025-09-30 | $8.18M 6-K · filed 2025-11-26 | |
| 2025-06-30 | $8.10M 6-K · filed 2025-08-28 | |
| 2024-12-31 | $7.18M 20-F · filed 2026-03-31 | |
| 2024-06-30 | $5.94M 6-K · filed 2024-08-28 | |
| 2023-12-31 | $7.53M 20-F · filed 2025-04-02 | |
| 2023-06-30 | $7.56M 6-K · filed 2023-08-09 | |
| 2022-12-31 | $11.77M 20-F · filed 2024-04-04 | |
| 2022-06-30 | $20.42M 6-K · filed 2022-08-04 | |
| 2021-12-31 | $31.93M 20-F · filed 2023-03-29 | |
| 2021-06-30 | $41.33M 6-K · filed 2021-08-05 | |
| 2020-12-31 | $40.13M 20-F · filed 2022-05-02 | $40.10M 20-F · filed 2021-03-18 |
| 2019-12-31 | $31.60M 20-F · filed 2020-03-12 | |
| 2018-12-31 | $60.00M 20-F · filed 2019-03-13 | |
| 2017-12-31 | $6.00M 20-F · filed 2018-03-13 |